{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:50Z","timestamp":1791704810423,"version":"4.3.4"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.103015","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T12:14:47Z","timestamp":1788696887000},"page":"103015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["H&E to recurrence score: A step forward, but not yet a substitute for genomic testing"],"prefix":"10.1016","volume":"73","author":[{"given":"Shiqiong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3582-3824","authenticated-orcid":false,"given":"Qinghua","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.tranon.2026.103015_bib0001","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1470-2045(25)00727-2","article-title":"Deep learning on histopathological images to predict breast cancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation study","volume":"27","author":"Shamai","year":"2026","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2026.103015_bib0002","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103015_bib0003","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10549-024-07303-z","article-title":"Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assay","volume":"206","author":"Wang","year":"2024","journal-title":"Breast. Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.tranon.2026.103015_bib0004","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1038\/s41467-025-57283-x","article-title":"Multimodal histopathologic models stratify hormone receptor-positive early breast cancer","volume":"16","author":"Boehm","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.tranon.2026.103015_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.tranon.2026.103015_bib0006","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.tranon.2026.103015_bib0007","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41591-024-02857-3","article-title":"Towards a general-purpose foundation model for computational pathology","volume":"30","author":"Chen","year":"2024","journal-title":"Nat. Med."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:31:53Z","timestamp":1791703913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":7,"alternative-id":["S1936523326003517"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103015","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H&E to recurrence score: A step forward, but not yet a substitute for genomic testing","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103015"}}